Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study

✍ Scribed by Julio García-Suárez; Helena Bañas; Ignacio Arribas; Dunia De Miguel; Teresa Pascual; Carmen Burgaleta

• Book ID: 108674090
• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 506 KB
• Volume: 136
• Category: Article
• ISSN: 0007-1048
• DOI: 10.1111/j.1365-2141.2006.06438.x